Drug Profile
Monoclonal antibody B4G7-gelonin conjugate
Latest Information Update: 15 May 1997
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Epidermal growth factor inhibitors; RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 08 May 1997 New profile
- 08 May 1997 No-Development-Reported for Cancer in Japan (Unknown route)